APP vs VRTX · P/E 61, rev $5.48B vs P/E 30, rev $12.00B
Applovin Corp (APP) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Applovin Corp (APP) is a advertising agencies company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported APP revenue for 2025-12-31 was $5.48B. Net income was $3.33B. Revenue was up 16.4% from 2024-12-31 to 2025-12-31. APP currently screens at market cap $113.70B and trailing P/E 61.0.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
APP currently screens at market cap $113.70B and trailing P/E 61.0. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the APP and VRTX stock pages for the full models.
Not investment advice.